April 16th 2024, 7:00pm
Pelabresib plus Jakafi led to a reduction in spleen size and was tolerable in patients with myelofibrosis, according to data from MANIFEST-2.
April 11th 2024, 5:00pm
I was surprised that COVID-19 taught me how to cope with the daily annoyances of cancer.
April 3rd 2024, 3:00pm
Childbirth rates have been reduced by 22% in women with MPNs, compared with women without MPNs, researchers found.
April 1st 2024, 7:00pm
The Food and Drug Administration approved multiple new therapies for blood cancer over the last few months.
March 22nd 2024, 1:00pm
The novel treatment elritercept received a Fast Track designation from the FDA to treat anemia in patients with MDS.
March 20th 2024, 7:00pm
An FDA committee voted that the benefits of Carvykti outweigh the risks for myeloma treatment, though concerns about secondary malignancies remain.
March 19th 2024, 9:00pm
Patients taking Tibsovo to treat MDS or AML may want to discuss the appropriate medications to treat and prevent infections, an expert said.
March 15th 2024, 7:00pm
The Oncologic Drug Advisory Committee voted that the benefits of imetelstat outweigh the risks for transfusion-dependent myelodysplastic syndrome and anemia.
March 8th 2024, 8:00pm
Attending follow-up appointments as blood cancer survivors can help prevent more dangerous outcomes, including secondary cancers, an expert told CURE®.
March 1st 2024, 2:00pm
Consulting physical therapy early on and speaking up to the health care team can help patients with blood cancer be more prepared for a hematopoietic stem cell transplant, an expert said.
‘Give Yourself Grace’ After a Cancer Diagnosis, Kristen Dahlgren Says
Urine Test Decreases Cystoscopies in Patients With Bladder Cancer
Recognizing and Managing Stress from Cancer
‘Landmark’ Findings Led to Alecensa Approval for ALK-Positive NSCLC